Cardiac valve or heart valve allows blood to flow in only one direction through the heart. Human heart consists of four valves. These valves open and closes compulsory on differential blood pressure on each side.
Increasing number of people with cardiovascular diseases and increasing number of cardiac surgery have stimulated the growth of the market. Additionally, increasing incident of diabetes and obesity, adoption of deskbound lifestyle rising geriatric population, and excessive use of tobacco and alcohol projected to propel the growth of the market.

The global Cardiac Valve market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Cardiac Valve volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cardiac Valve market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cardiac Valve in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cardiac Valve manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Boston Scientific
St. Jude Medical
LivaNova
Symetis
Jenavalve Technology
CryoLife
TTK HealthCare
Colibri Heart Valve
Lepu Medical Technology
Braile Biomédica

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Trans-Catheter Heart Valve
Tissue Heart Valve
Mechanical Heart Valve
Others

Segment by Application
Cardiac Research Institute
Hospital & Clinics
Others